ES8302457A1 - Un procedimiento para preparar soluciones acu0sas a base de una sal de sulfonamida acuosoluble, un potenciador de sulfo-namida y un aldehido. - Google Patents

Un procedimiento para preparar soluciones acu0sas a base de una sal de sulfonamida acuosoluble, un potenciador de sulfo-namida y un aldehido.

Info

Publication number
ES8302457A1
ES8302457A1 ES500635A ES500635A ES8302457A1 ES 8302457 A1 ES8302457 A1 ES 8302457A1 ES 500635 A ES500635 A ES 500635A ES 500635 A ES500635 A ES 500635A ES 8302457 A1 ES8302457 A1 ES 8302457A1
Authority
ES
Spain
Prior art keywords
manufacature
pharmaceutical preparations
sulfonamide
potentiator
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500635A
Other languages
English (en)
Other versions
ES500635A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8302457A1 publication Critical patent/ES8302457A1/es
Publication of ES500635A0 publication Critical patent/ES500635A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DISOLUCIONES ACUOSAS A BASE DE UNA SAL DE SULFONAMIDA ACUOSOLUBLE, UN POTENCIADOR DE SULFONAMIDA Y UN ALDEHIDO. CONSISTE EN MEZCLAR UNA DISOLUCION ACUOSA DE UNA SAL DE SULFONAMIDA Y UN POTENCIADOR DE SULFONAMIDA CON UNA DISOLUCION ACUOSA DE ALDEHIDO MANTENIENDO UNA RELACION MOLAR POTENCIADOR: ALDEHIDO Y POTENCIADOR SULFONAMIDA <067> 1:1, Y HACER REACCIONAR LA MEZCLA A UNA TEMPERATURA DE 80<025>C HASTA SU COMPLETA DISOLUCION. ESTAS COMPOSICIONES TIENEN APLICACIONES EN MEDICINA HUMANA Y VETERINARIA PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS.
ES500635A 1980-03-25 1981-03-24 Un procedimiento para preparar soluciones acu0sas a base de una sal de sulfonamida acuosoluble, un potenciador de sulfo-namida y un aldehido. Granted ES500635A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2328/80A CH647412A5 (de) 1980-03-25 1980-03-25 Pharmazeutische praeparate.

Publications (2)

Publication Number Publication Date
ES8302457A1 true ES8302457A1 (es) 1983-02-01
ES500635A0 ES500635A0 (es) 1983-02-01

Family

ID=4231246

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500635A Granted ES500635A0 (es) 1980-03-25 1981-03-24 Un procedimiento para preparar soluciones acu0sas a base de una sal de sulfonamida acuosoluble, un potenciador de sulfo-namida y un aldehido.

Country Status (46)

Country Link
US (1) US4532245A (es)
EP (1) EP0037501B1 (es)
JP (1) JPS56145224A (es)
KR (1) KR840002014B1 (es)
AR (1) AR231230A1 (es)
AT (2) ATE8460T1 (es)
AU (1) AU545277B2 (es)
BG (1) BG35324A3 (es)
BR (1) BR8101752A (es)
CA (1) CA1158158A (es)
CH (1) CH647412A5 (es)
CS (1) CS235086B2 (es)
CU (1) CU35438A (es)
DD (1) DD157536A5 (es)
DE (2) DE3111067A1 (es)
DK (1) DK158829C (es)
DZ (1) DZ276A1 (es)
ES (1) ES500635A0 (es)
FI (1) FI72876C (es)
FR (1) FR2479211A1 (es)
GB (1) GB2073587B (es)
GR (1) GR74453B (es)
HK (1) HK78184A (es)
HU (1) HU185415B (es)
IE (1) IE51065B1 (es)
IL (1) IL62432A (es)
IN (1) IN152637B (es)
IS (1) IS2626A7 (es)
IT (1) IT1210991B (es)
KE (1) KE3419A (es)
LU (1) LU83246A1 (es)
MC (1) MC1372A1 (es)
MT (1) MTP884B (es)
MW (1) MW881A1 (es)
MY (1) MY8500681A (es)
NL (1) NL8101152A (es)
NO (1) NO158656C (es)
NZ (1) NZ196553A (es)
OA (1) OA06776A (es)
PH (1) PH17972A (es)
PT (1) PT72727B (es)
RO (1) RO82024B (es)
SE (1) SE8101884L (es)
SG (1) SG43384G (es)
ZA (1) ZA811843B (es)
ZW (1) ZW4881A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3266202D1 (en) * 1981-09-23 1985-10-17 Hoffmann La Roche Manufacturing process of sulfonamide-potentiator solutions and a new sulfanilamide
JPS59118708A (ja) * 1982-12-27 1984-07-09 Dai Ichi Seiyaku Co Ltd 液状合剤
DE4331147A1 (de) * 1993-09-14 1995-03-16 Nycomed Arzneimittel Gmbh Intravenös verabreichbare, wäßrige Lösung
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
CA2598668A1 (en) * 2005-02-25 2006-09-08 Mutual Pharmaceutical Company, Inc. Dosage forms of antibiotics and combinations of antibiotics and symptomatic relief agents
NZ563236A (en) 2005-05-13 2010-12-24 Topotarget Uk Ltd Pharmaceutical formulations of N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide, aka PXD-101, and arginine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH247344A (de) * 1945-11-29 1947-02-28 Ciba Geigy Verfahren zur Herstellung eines neuen Kondensationsproduktes des Sulfathiazols.
NL64566C (es) * 1946-12-19
NL78195C (es) * 1946-12-19
AT174151B (de) * 1949-03-24 1953-03-10 Boehringer & Soehne Gmbh Verfahren zur Hydrophilisierung der Sulfonamide
DE836079C (de) * 1950-09-17 1952-04-07 Inh Apoth E Rath Verfahren zur Herstellung haltbarer Loesungen aus Sulfonamiden und Hexamethylentetramin
DE954725C (de) * 1953-01-21 1956-12-20 Chemie Linz Ag Verfahren zur Herstellung von wasserloeslichen Sulfonamidpraeparaten
GB792449A (en) * 1955-02-21 1958-03-26 Cilag Ltd Condensation products of sulphaguanidine and formaldehyde and their production
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung

Also Published As

Publication number Publication date
MC1372A1 (fr) 1982-01-19
AT374365B (de) 1984-04-10
AU6851381A (en) 1981-10-01
EP0037501B1 (de) 1984-07-18
HK78184A (en) 1984-10-26
IE810657L (en) 1981-09-25
DE3111067A1 (de) 1982-02-18
ZW4881A1 (en) 1981-10-14
AU545277B2 (en) 1985-07-11
DE3164826D1 (en) 1984-08-23
CS235086B2 (en) 1985-04-16
IL62432A0 (en) 1981-05-20
AR231230A1 (es) 1984-10-31
SE8101884L (sv) 1981-09-26
EP0037501A1 (de) 1981-10-14
IE51065B1 (en) 1986-09-17
IS2626A7 (is) 1981-09-26
IT1210991B (it) 1989-09-29
GB2073587B (en) 1984-02-29
ZA811843B (en) 1982-04-28
ATA137581A (de) 1983-09-15
GB2073587A (en) 1981-10-21
IN152637B (es) 1984-02-25
FR2479211B1 (es) 1984-01-13
FR2479211A1 (fr) 1981-10-02
DZ276A1 (fr) 2004-09-13
RO82024A (ro) 1984-05-23
JPH0158166B2 (es) 1989-12-11
FI810874L (fi) 1981-09-26
DK158829B (da) 1990-07-23
NO811003L (no) 1981-09-28
GR74453B (es) 1984-06-28
NZ196553A (en) 1983-11-18
IT8119892A0 (it) 1981-02-20
SG43384G (en) 1985-03-08
HU185415B (en) 1985-02-28
KE3419A (en) 1984-08-10
NO158656C (no) 1988-11-23
DD157536A5 (de) 1982-11-17
JPS56145224A (en) 1981-11-11
KR840002014B1 (ko) 1984-11-05
BG35324A3 (en) 1984-03-15
DK158829C (da) 1990-12-24
CU35438A (en) 1983-04-06
PH17972A (en) 1985-02-22
US4532245A (en) 1985-07-30
ES500635A0 (es) 1983-02-01
LU83246A1 (fr) 1983-02-22
CH647412A5 (de) 1985-01-31
IL62432A (en) 1984-07-31
NO158656B (no) 1988-07-11
OA06776A (fr) 1982-06-30
PT72727B (en) 1983-01-10
ATE8460T1 (de) 1984-08-15
MW881A1 (en) 1982-06-09
PT72727A (en) 1981-04-01
CA1158158A (en) 1983-12-06
MTP884B (en) 1984-06-05
NL8101152A (nl) 1981-10-16
MY8500681A (en) 1985-12-31
FI72876B (fi) 1987-04-30
BR8101752A (pt) 1981-09-29
FI72876C (fi) 1987-08-10
DK94381A (da) 1981-09-26
RO82024B (ro) 1984-07-30
KR830004845A (ko) 1983-07-20

Similar Documents

Publication Publication Date Title
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
CY1250A (en) N-heterocyclyl-4-piperdinamines,methods for their preparation and pharmaceutical compositions comprising them
IT8026587A0 (it) Eteri basici, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
IL56413A (en) Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them
IT8322173A0 (it) Composizioni analgesiche e antinfiammatorie migliorate, contenenti caffeina.
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
ES8302457A1 (es) Un procedimiento para preparar soluciones acu0sas a base de una sal de sulfonamida acuosoluble, un potenciador de sulfo-namida y un aldehido.
DE2862404D1 (en) Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
IL61702A (en) Anagesic tetrapeptides,their preparation and pharmaceutical compositions comprising them
ATE13184T1 (de) Aldehydaddukte des triamterens und sie enthaltende pharmazeutische zusammensetzungen.
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
NL7803418A (nl) 15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten.
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
IT8320840A0 (it) Preparazioni farmaceutiche con azione citostatica.
NL7904311A (nl) Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten.
ES465578A1 (es) Procedimiento para la obtencion de preparados farmaceuticos diureticos, antihipertensivos y cardiales
IT7924364A0 (it) Preparati farmaceutici con aumentata azione ipotensiva.
DK165976A (da) Afstandsorgan til i betonovertrek til ror at danne en fleksibel samling
IT1170361B (it) Cianoguanidine, procedimento per ottenerle e composizioni farmaceutiche che le contengono
DE3168920D1 (en) Prostaglandin derivatives, their preparation and pharmaceutical compositions
CA1001635A (fr) Derive de la l hydroxy-4 proline, sa preparation et les compositions medecinales qui le contiennent
DE2861571D1 (en) Amidines, their preparation and pharmaceutical compositions containing them.